BioLine Rx Ltd (BLRX)
0.64
+0.03
(+4.64%)
USD |
NASDAQ |
Apr 29, 16:00
0.6405
0.00 (0.00%)
Pre-Market: 20:00
BioLine Rx Net Income (Quarterly): -13.88M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -13.88M |
| September 30, 2023 | -16.02M |
| June 30, 2023 | -18.54M |
| March 31, 2023 | -12.16M |
| December 31, 2022 | -5.731M |
| September 30, 2022 | -6.847M |
| June 30, 2022 | -7.443M |
| March 31, 2022 | -4.93M |
| December 31, 2021 | -4.304M |
| September 30, 2021 | -5.716M |
| June 30, 2021 | -6.842M |
| March 31, 2021 | -10.19M |
| December 31, 2020 | -11.99M |
| September 30, 2020 | -4.618M |
| June 30, 2020 | -6.77M |
| March 31, 2020 | -6.645M |
| December 31, 2019 | -9.868M |
| September 30, 2019 | -3.938M |
| June 30, 2019 | -5.485M |
| March 31, 2019 | -6.155M |
| December 31, 2018 | -5.652M |
| September 30, 2018 | -6.324M |
| June 30, 2018 | -4.788M |
| March 31, 2018 | -6.198M |
| December 31, 2017 | -7.357M |
| Date | Value |
|---|---|
| September 30, 2017 | -7.243M |
| June 30, 2017 | -4.897M |
| March 31, 2017 | -4.855M |
| December 31, 2016 | -4.285M |
| September 30, 2016 | -4.334M |
| June 30, 2016 | -3.735M |
| March 31, 2016 | -3.489M |
| December 31, 2015 | -3.652M |
| September 30, 2015 | -1.626M |
| June 30, 2015 | -4.81M |
| March 31, 2015 | -4.311M |
| December 31, 2014 | -4.193M |
| September 30, 2014 | -0.70M |
| June 30, 2014 | -4.067M |
| March 31, 2014 | -2.115M |
| December 31, 2013 | -4.111M |
| September 30, 2013 | -4.951M |
| June 30, 2013 | -4.268M |
| March 31, 2013 | -3.514M |
| December 31, 2012 | -7.254M |
| September 30, 2012 | -5.736M |
| June 30, 2012 | -2.891M |
| March 31, 2012 | -4.827M |
| December 31, 2011 | -3.576M |
| September 30, 2011 | -2.120M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-18.54M
Minimum
Jun 2023
-3.938M
Maximum
Sep 2019
-8.523M
Average
-6.842M
Median
Jun 2021
Net Income (Quarterly) Benchmarks
| Compugen Ltd | 9.713M |
| Pluri Inc | -4.905M |
| XTL Biopharmaceuticals Ltd | -0.215M |
| Can Fite Biofarma Ltd | -1.652M |
| BiomX Inc | -5.491M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 4.80M |
| Total Expenses (Quarterly) | 16.66M |
| EPS Diluted (Quarterly) | -0.15 |
| Enterprise Value | 17.94M |
| Profit Margin (Quarterly) | -289.2% |
| Earnings Yield | -140.6% |